V5 Ultimate
Pharmaceutical · How V5 Runs

How V5 Ultimate runs a pharmaceutical site, end to end.

Eleven touchpoints — from supplier onboarding to a queried recall — that share one immutable ledger. Mapped to 21 CFR 211, ICH Q7/Q9/Q10, EU GMP Annex 11 and Part 11. Read it as a playbook, audit it as a checklist.

Start free trial
21 CFR 211Part 11ICH Q7ICH Q9ICH Q10EU GMP Annex 11GAMP 5DSCSAEU FMD
ONE IMMUTABLE LEDGER21 CFR 211 · Part 11 · ICH Q7 · ICH Q10 · EU GMP Annex 11 · DSCSA01Supplierqual'd02Receivequarantine03MMRv3.204Kioskdispense05BMRimmutable06QA2-sig07ShipDSCSAe-sige-sig2-sige-sigThe evidence chainEvery action signs the ledger — nothing is re-keyed at the end.
Executive summary

One ledger, every touchpoint — from supplier to recall in seconds.

V5 Ultimate runs a pharmaceutical site as one connected system, not a stack of integrations. Materials, MMR/BMR, kiosk execution, QC, deviations, packaging, release, distribution and the entire PQS (documents, training, audits, APR, stability, EM, cleaning, equipment, complaints, PV) all write to the same immutable, identity-verified ledger.

The pay-off is operational: review-by-exception BMRs reviewed in 20–40 min instead of 4 hours, APR/PQR cycles cut from 4–6 weeks to 3–5 days per product, and a recall that resolves as a query — forward and backward from any node — not a project.

This playbook walks you through 11 traceability touchpoints and the 17 quality-system modules that wrap them, grouped into 8 readable parts. Every section anchors to the relevant clauses of 21 CFR 211, ICH Q7/Q9/Q10, EU GMP, Annex 11 and Part 11.

11
Traceability touchpoints
8
Thematic parts
30+
Regulatory anchors
Part I

Foundations

Why traceability is the spine, and the eleven-node map.

01

Why traceability is the product, not a feature

In pharmaceutical manufacturing, the unit that ships is the batch — but the unit a regulator audits is the evidence chain behind it.

Floor actionscan · weigh · e-sigactor + tsSTEP 01Append-only rowDB trigger writes oncesha256STEP 02BMR snapshotfrozen at releaseWO boundSTEP 03PDF renderfrom snapshot onlydeterministicSTEP 04Inspector packexported on demand21 CFR 11STEP 05ALCOA+ lineageAttributable · Legible · Contemporaneous · Original · Accurate · + Complete · Consistent · Enduring · AvailableOne origin event. No re-keying. No reconciliation.
ALCOA+ in one picture: one origin event, replayable downstream.

Every gram of API, every cleaning record, every operator e-signature, every deviation, every counter-reading on a tablet press: if it isn't connected forward to the released batch and backward to the lot of starting material that fed it, the batch is unsafe at law. 21 CFR 211.188 doesn't ask for 'a record' — it asks for the complete history. EU GMP Chapter 4 says the same thing in different words.

Most pharma stacks treat traceability as an afterthought — bolt-on reports stitched together at audit time from paper logbooks, MES exports, LIMS spreadsheets, and a hand-typed BMR. V5 Ultimate inverts that: traceability is the spine the platform is built around. Every action on the floor, in QC, in the warehouse, on a supplier portal — writes one immutable record, with the lot, batch, operator, instrument, and timestamp baked in at the moment it happens.

The customer experience that follows is the obvious one: a recall that takes seconds, an inspector who asks for the BMR and gets a tab-complete answer, a CAPA that closes with linked evidence instead of a Word document and a prayer.

Regulatory anchors
  • 21 CFR 211.188Batch production and control records
  • EU GMP Ch. 4Documentation — complete history of each batch
  • ICH Q10Pharmaceutical Quality System lifecycle
02

The end-to-end traceability chain at a glance

Eleven touchpoints, one record. The diagram below is the map — the rest of this page is the legend.

  1. 01
    Supplier
  2. 02
    Receive
  3. 03
    Warehouse
  4. 04
    MMR
  5. 05
    Release
  6. 06
    Kiosk
  7. 07
    IPC / QC
  8. 08
    Dev / CAPA
  9. 09
    Pack & serialise
  10. 10
    QA release
  11. 11
    Distribute
One immutable ledger underneath. Every node writes; nothing is re-keyed.

Read left-to-right. Every node writes to the same immutable ledger, and every node carries forward the lot, batch, operator, and instrument context from the node before it. Nothing is re-keyed; nothing is reconciled at the end.

Part II

Materials in

Supplier → quarantine → warehouse, status-controlled.

03

Touchpoint 1 — Supplier onboarding & qualification

A pharma supplier isn't approved until their evidence is on file and their COAs land in the right place automatically.

V5 holds the supplier master with the qualification status, scope (material × site × grade), audit dates, and approved alternates. New suppliers go through a portal-driven onboarding: company info, regulatory licences, GMP/GDP certificates, allergen and BSE/TSE statements, change-notification commitments. Quality reviews, signs, and the supplier moves to 'Approved (scoped)'.

Re-qualification runs on a calendar — V5 chases expiring certificates automatically through the supplier portal and escalates if a document misses its window. The release engine refuses to consume any material whose supplier × material combination isn't currently approved. There is no 'override and ship' button; there is a quarantine-pending review.

  • Scoped approval: supplier × material × site × grade
  • Auto-chased re-qualification with portal acks
  • COAs auto-attach to receipt by lot
  • Audit trail of every change to supplier status
Regulatory anchors
  • ICH Q7 §7Materials management & supplier qualification
  • EU GMP Ch. 5Starting & packaging materials
04

Touchpoint 2 — Receiving, sampling & quarantine

Every receipt lands in quarantine and stays there until QC says otherwise. The system enforces the wall, not a sticker.

A receiving operator scans the delivery, V5 checks the supplier/material combination against the approved master, prints (or e-stamps) a quarantine label per container, and creates lot records with a 1:1 link to the COA, the PO, the carrier's docs, and the temperature log if the material is cold-chain. Status is Quarantine until QC dispositions it.

Sampling is driven by a sampling plan derived from material class (API, excipient, primary packaging, label). V5 generates the sample request, prints the sample labels with traceable IDs, and the LIMS bridge carries the results back to the same lot. Disposition flips the lot to Released, Rejected, or Conditional — and every kiosk in the plant sees the change in real time.

  • Quarantine is a status, not a sticker — enforced at every consume event
  • COA, carrier docs, temperature logs all attached at the lot level
  • LIMS results return to the same lot record automatically
  • Conditional release supported with mandatory close-out
Regulatory anchors
  • 21 CFR 211.84Testing & approval/rejection of components
  • ICH Q7 §7.30Sampling of materials
05

Touchpoint 3 — Warehouse, lots & status control

Lot status drives what the warehouse can pick. The pick gun is the policy engine, not a barcode scanner.

Every bin, every container, every split lot carries a status: Quarantine, Released, On-Hold, Quarantine-Excursion, Rejected, Expired. Pickers see only what's pickable for the current work order — V5 hides the rest. FEFO is enforced by default; overrides require a documented reason and a second signature.

Movements (putaway, transfer, decant, split) write to the same ledger as the rest of the platform. A lot can be split into N child containers, each inheriting parentage; when you trace forward later, every child remembers the parent and the operator who did the split.

Cycle counts, recall sweeps, and stock-take reconciliations are filterable by status and supplier — a recall doesn't start with a spreadsheet, it starts with a query.

  • Status-aware FEFO with documented overrides
  • Parent/child lot genealogy on every split
  • Cycle count + recall filterable by supplier × lot
Regulatory anchors
  • EU GDPGood Distribution Practice — storage & segregation
Part III

Recipe & execution

MMR, snapshot, kiosk, in-process QC.

06

Touchpoint 4 — Master Manufacturing Record (MMR)

The MMR is the controlled recipe. In V5 it's a versioned, signed, machine-readable object — not a Word document.

The MMR for a finished product holds the BOM with target weights and tolerances, the routing (stations, instruments, environmental conditions), the in-process checks with sampling rules, the cleaning protocol between batches, the labelling artwork, and the release specification. Every field is a structured slot the kiosk can render and the BMR can snapshot.

MMRs go through a two-signature approval workflow (author + QA approver, identity-verified e-signatures, Part 11). Once Effective, the MMR is locked; any change goes through change control (see §10) and produces a new minor or major version with effective dates. The release engine binds the work order to a specific MMR version; you cannot 'use the latest' by accident.

  • Structured BOM, routing, IPC, cleaning, artwork, spec
  • Two-signature, Part 11 e-signatures, immutable once Effective
  • Versioned with effective-date binding to work orders
Regulatory anchors
  • 21 CFR 211.186Master production & control records
  • ICH Q7 §6.40Master production instructions (Master Production and Control Records)
07

Touchpoint 5 — Work order release & MMR snapshot

Releasing a work order takes a snapshot. From that moment, the batch carries its own copy of the recipe — frozen forever.

MMR v3.2BOM · Routing · IPCSpec · ArtworkEFFECTIVE · 2-SIGSNAPon releaseWO-2026-0418Bound to MMR v3.2Frozen recipeRELEASED · sha256:a4f9…runs even ifMMR revisesBMR (this batch)Filled by kiosk+ IPC + dev + sigsIMMUTABLEMMR v3.3 (later revision)does NOT affect WO-2026-0418
The WO carries a frozen copy of MMR v3.2. Later revisions don't disturb this batch.

When planning releases a work order, V5 binds it to a specific MMR version and copies that version into the batch's BMR shell. Even if the MMR is revised next week, this batch will always reference what was Effective at release time. The snapshot includes BOM, tolerances, instrument requirements, IPC plan, cleaning, artwork, and spec.

Operator availability, training currency, instrument calibration status, and clean-room certification status are all checked at release. A work order cannot be released to a station with an out-of-cal scale or an operator whose training expired yesterday. The check is automated and immutable.

  • Immutable BMR snapshot at the moment of release
  • Operator training + instrument calibration gated at release
  • Concurrent batches kept logically isolated by work order
Regulatory anchors
  • 21 CFR 211.100Written procedures; deviations
  • 21 CFR 211.68Automatic, mechanical & electronic equipment
08

Touchpoint 6 — Kiosk dispense & weighing

The kiosk is the floor. Every weight is verified against the BMR tolerance the moment it lands on the scale.

An operator scans the work order, V5 walks them through the dispense list step by step: scan the lot, scan the container, place on the validated scale, wait for stable, V5 captures the reading directly from the instrument. The reading must fall inside the tolerance from the snapshotted BMR — if it doesn't, the kiosk holds and forces a deviation or a re-dispense before continuing.

Every event writes to the BMR in real time, identity-verified. Operators can't skip a step, can't proceed past a hold, and can't enter a value by hand for a connected instrument. The BMR fills itself; the operator does the work.

  • Direct instrument capture — no hand-entered weights for connected scales
  • Hard stop on out-of-tolerance with mandatory deviation
  • Identity-verified e-sig on every step (Part 11)
  • Concurrent-station support with logical isolation per work order
Regulatory anchors
  • 21 CFR 211.101Charge-in of components
  • 21 CFR 211.103Calculation of yield
  • 21 CFR Part 11Electronic records & signatures
09

Touchpoint 7 — In-process and finished QC

QC is not a parallel system. The IPC plan from the MMR drives the sampling, and the result returns to the BMR.

In-process checks (mass uniformity, hardness, friability, disintegration, assay on intermediates, microbial sampling on a fill line) are scheduled by the BMR's IPC plan. V5 raises the sample request, prints the sample label with traceable ID, and accepts the result — either entered at the kiosk by a trained tester or returned from a LIMS bridge.

Out-of-spec triggers an automatic hold on the affected sub-lot and a deviation record. Trending across batches is continuous (CpK, control charts) so a drift toward spec gets escalated before a single batch goes out-of-spec.

  • IPC plan driven by MMR; sampling auto-scheduled
  • OOS triggers sub-lot hold + deviation automatically
  • Trending (CpK, control charts) continuous across batches
Regulatory anchors
  • 21 CFR 211.110Sampling & testing of in-process materials
  • ICH Q9Quality risk management informing sampling plans
Part IV

Quality events

Every hold lands in one queue.

10

Touchpoint 8 — Deviations, NCRs, CAPA & change control

Every hold raised on the floor lands in the same quality module. No second system, no copy-and-paste, no orphans.

When the kiosk holds on an out-of-tolerance dispense, an OOS IPC, or a temperature excursion, V5 opens a Deviation linked to the work order, the step, the operator, the instrument, and the affected lot. QA triages, classifies (planned / unplanned, minor / major / critical), runs an impact assessment against other batches, and routes for CAPA if needed.

CAPAs are tracked to root cause with effectiveness checks at agreed intervals. Change control governs everything from MMR revisions to supplier substitutions to instrument firmware upgrades — each change with a risk assessment, validation impact, training impact, and a controlled effective date.

  • Deviation auto-linked to work order, step, operator, instrument, lot
  • Classification + impact assessment workflow (planned/unplanned, minor/major/critical)
  • CAPA tracked to root cause with timed effectiveness checks
  • Change control with risk, validation, training, and effective date
Regulatory anchors
  • ICH Q10 §3.2.2CAPA system
  • ICH Q9Quality risk management
  • 21 CFR 211.192Production record review & deviations
Part V

Pack to customer

Serialisation, release, distribution, recall.

11

Touchpoint 9 — Packaging, labelling & serialization

The serialised unit is the smallest customer-facing record. V5 carries the BMR all the way down to it.

Packaging routings run the same way as manufacturing: a kiosk-led step list, reconciled label counts, line-clearance checks before any new batch enters the line, and a verified label artwork against the MMR. Serialisation (GS1 SGTIN, aggregation through bundle / case / pallet) writes to the same ledger; every SSCC carries the parent batch and a full hierarchy upward.

EU FMD (2D Data Matrix + tamper-evident) and US DSCSA (EPCIS event reporting) are first-class outputs, not adapters. When a customer asks 'which case is this serial in, on which pallet, on which truck?' the answer is one query.

  • Line clearance with photographic evidence before each new batch
  • Reconciled label counts (issued / applied / destroyed / returned)
  • GS1 SGTIN serialisation + full aggregation hierarchy
  • EU FMD + US DSCSA event reporting built-in
Regulatory anchors
  • 21 CFR 211.122Materials examination & usage criteria — packaging & labelling
  • DSCSADrug Supply Chain Security Act (US)
  • EU FMD 2011/62/EUFalsified Medicines Directive (EU)
12

Touchpoint 10 — QA review & batch release (BMR)

Review by exception. The BMR is built as the line runs, not assembled afterwards.

By the time the last step is signed, the BMR is complete: every dispense, every IPC, every deviation, every CAPA reference, every cleaning record, every operator e-signature, every instrument calibration evidence. QA reviews by exception — V5 highlights anything that wasn't a clean pass, and the reviewer disposition is the second of the two-signature release per 21 CFR 211.188.

Release is gated by: all deviations dispositioned, all OOS closed, all open CAPAs assessed for impact, expiry date calculated from the established shelf-life model, and a stability commitment registered if applicable. A released batch generates the Certificate of Analysis from the same data — no re-typing.

  • Review-by-exception highlights anything not green
  • Two-signature release (preparer + independent QA), Part 11
  • CoA generated from the same data — never re-typed
  • Shelf-life model drives expiry calc and stability registration
Regulatory anchors
  • 21 CFR 211.188Batch production & control records
  • 21 CFR 211.192Production record review
  • EU GMP Ch. 4 §4.20Batch documentation requirements
13

Touchpoint 11 — Distribution, complaints & recall

A recall in V5 is a query, not a project. The lookback is forward and backward from any node.

Recall lookback timelineFrom recall trigger to drafted FDA report — measured in minutes, not weeksT+0sRecall triggerQA flips lot to RecallSTEP 01T+12sBackward traceSupplier · lot · MMRSTEP 02T+43s100% units foundBottle · case · palletSTEP 03T+2m 11sCustomers notifiedPortal + DSCSA pushSTEP 04T+8mFDA report draftedAuto from ledgerSTEP 05Bidirectional from any node — bottle ⇄ case ⇄ pallet ⇄ batch ⇄ lot ⇄ supplier
One ledger, one query. Forward and backward from any node.

Released batches ship with full pedigree under DSCSA / EU FMD: every serialised unit's chain of custody is in the ledger before the truck leaves. Complaints land via a customer portal or a CSM ticket, route to QA, and link forward to a complaint investigation file that can spawn deviations and CAPAs.

When a recall is triggered, V5 answers four questions instantly: which lots of which materials are implicated, which batches consumed them, which units shipped from those batches, and which customers received which units. A trigger from any node propagates in seconds; no analyst, no spreadsheet, no overnight reconciliation.

  • Full pedigree shipped before the truck leaves
  • Recall lookback forward & backward from any node
  • Complaint → investigation → deviation → CAPA — one chain
Regulatory anchors
  • 21 CFR 211.196Distribution records
  • 21 CFR 211.198Complaint files
  • 21 CFR 7.40FDA recall guidance
Part VI

Quality system

PQS, documents, training, APR, audits.

14

Quality system controls underpinning every step

The PQS (ICH Q10) isn't a separate module — it's the substrate every other workflow sits on.

User roles & permissions, training matrix with currency enforcement, instrument calibration with auto-hold on lapsed cal, validated cleaning protocols with verification swab results, environmental monitoring with trended alert/action limits, supplier qualification status, deviation & CAPA workflow, change control, internal audit program, management review with KPI dashboards. Each is a first-class object with its own lifecycle and audit trail.

The platform doesn't 'support' the PQS — the PQS is what the platform is. Every action everywhere checks the PQS state and refuses to proceed if a control is missing or expired.

  • Training currency enforced at the kiosk, not on paper
  • Calibration auto-hold on lapsed instrument cal
  • EM trending with alert/action limit escalations
  • Internal audit program + management review dashboards
Regulatory anchors
  • ICH Q10Pharmaceutical Quality System
  • 21 CFR 211 Subpart BOrganization and personnel
15

Document control & SOP lifecycle

Every controlled document — SOP, policy, work instruction, form, spec — lives inside V5 with author / reviewer / approver workflow, periodic review, and Part 11 e-signatures.

V5 ships a full Document Management System: hierarchical taxonomy (Quality Manual → Policy → SOP → Work Instruction → Form), document numbering rules per site, draft / in-review / effective / superseded / obsolete statuses, and configurable workflow (e.g. author → SME → QA → site head). Read-acknowledgement assignments push the new SOP to every affected role and block kiosk login until the operator has signed the read-and-understood.

Periodic review is calendar-driven — V5 raises a review task at the configured cadence (typically 12, 24 or 36 months), routes it to the document owner, and escalates if it slips. Change requests link to deviations, CAPAs, audit findings, or change controls so the 'why' is always inside the file. Redlines are diff-tracked between versions; the audit trail captures who saw what, when, on which device.

  • Draft → review → approve → effective workflow with Part 11 e-sigs
  • Read-and-understood assignments tied to roles, blocking access until signed
  • Periodic review schedule with auto-escalation
  • Version diffing with full audit trail of who saw which revision
  • Linked source-of-change (deviation / CAPA / audit / change control)
Regulatory anchors
  • 21 CFR 211.180General requirements for records & reports
  • EU GMP Ch. 4Documentation lifecycle
  • ICH Q10 §3.1.1Document management within the PQS
16

Training & competency management

Training isn't a folder of certificates — it's a live matrix that gates every action on the floor.

V5 holds the training matrix as role × competency × currency. New hires get a curriculum auto-assigned on day one (induction, GMP basics, gowning, site safety, role-specific SOPs); completion is recorded with quiz scores, observation sign-offs from a qualified trainer, and a re-qualification interval. Competencies are linked to physical actions: weigh-out, IPC, line clearance, batch review, supplier audit.

The kiosk and BMR enforce the matrix at the moment of action. An operator whose 'tablet press operation' competency expires at midnight can't start a press shift the next morning until requalified. Trainer qualifications are themselves competencies — only qualified trainers can sign off another operator's competency record. Re-training is auto-scheduled when an SOP is revised, when a deviation root cause cites training, or when a metric (e.g. operator-attributable defects) trends adverse.

  • Role × competency × currency matrix, machine-readable
  • Curriculum auto-assignment on hire and on role change
  • Kiosk gate: expired competency = no action permitted
  • Trainer qualification chain (qualified-to-qualify)
  • Re-training triggered by SOP revision, deviation, or trended drift
Regulatory anchors
  • 21 CFR 211.25Personnel qualifications & training
  • EU GMP Ch. 2Personnel — training program
  • ICH Q10 §2.3.1Trained personnel as a PQS enabler
17

Annual Product Review (APR / PQR)

Year-on-year product quality is a query, not a project. V5 assembles the Annual Product Review continuously and renders it on demand.

APR / PQR — continuous compilationEvery batch, IPC, OOS, deviation and complaint feeds the review as it happensJanbatch · IPCFebbatch · IPCMarbatch · IPCAprbatch · IPCMaybatch · IPCJunbatch · IPCJulbatch · IPCAugbatch · IPCSepbatch · IPCOctbatch · IPCNovbatch · IPCDecbatch · IPCAnnual Product ReviewTrends · CpK · OOS · CAPAStability · Complaints · PV211.180(e) · ICH Q10CpK trend chartOOS / CAPA registerStability projectionSigned PQR PDF
APR / PQR assembles continuously — not a 4-week scramble at year end.

21 CFR 211.180(e) (APR, US) and EU GMP Chapter 1 §1.10 (PQR, EU) both require a written annual review covering at minimum: every batch produced and its release outcome, all in-process and finished-product test results with trends, all deviations and OOS, all returned / complained / recalled product, all changes made to the product, the qualification status of equipment and utilities, and stability programme results.

Because every one of those data points is already in the ledger, V5 maintains a live APR / PQR workspace per product per year. Trend charts (CpK, OOS rate, deviation by category, recovery yield) refresh nightly. At year-end, QA reviews the assembled draft, adds the executive summary and the proposed actions, signs the report, and exports a regulator-ready PDF — typically a week of work instead of a quarter.

  • Per-product, per-year workspace continuously assembled from the ledger
  • Trended CpK, OOS rate, RFT, deviation categories, yield
  • Stability results, returns, complaints, recalls, changes — all pre-loaded
  • Reviewer-led completion with two-signature sign-off
  • Export pack: PDF + appendix datasets for regulators
Regulatory anchors
  • 21 CFR 211.180(e)Annual Product Review (US)
  • EU GMP Ch. 1 §1.10Product Quality Review (EU)
  • ICH Q10 §2.6Management review of process performance and product quality
18

Audit & inspection management

Internal audits, supplier audits, and regulatory inspections all run through one program — with findings, CAPAs, and verification linked to the same ledger.

V5 holds the audit programme: scope (internal area, supplier, contract manufacturer), risk-based frequency, lead auditor assignment, checklist library aligned to ICH Q10, ISO 19011, and applicable GMP chapters. Audit execution captures findings inline with photographs, evidence references, classification (critical / major / minor / observation), and immediate corrections.

Findings auto-route to the affected area, link to the CAPA workflow, and stay open in the management dashboard until effectiveness is verified at the configured interval. Regulatory inspections (FDA, EMA, MHRA, local authority) use a dedicated Investigator Mode — a read-only scoped view with one-click evidence export, an inspection log capturing every document shown, and a real-time response workspace for the inspection team to draft, review, and submit Form 483 responses or equivalent.

  • Internal + supplier + contract manufacturer audit programme
  • Risk-based frequency with auto-scheduling
  • Findings → CAPA → effectiveness verification, one chain
  • Investigator Mode: read-only scoped view + evidence export log
  • Real-time 483-response workspace with version control
Regulatory anchors
  • 21 CFR 211.180(e)Records review
  • EU GMP Ch. 9Self-inspection programme
  • ICH Q10 §3.2.4Internal audit (self-inspection)
  • ISO 19011Auditing management systems
Part VII

Risk & operations

Risk, stability, EM, cleaning, equipment, complaints.

19

Risk management & FMEA

ICH Q9 is lived in every workflow — the risk register isn't a spreadsheet, it's a first-class object the rest of the platform consults.

V5 holds product risk assessments (FMEA, HACCP-style hazard analysis, PHA), process risk assessments per routing, supplier risk profiles, and computer-system risk assessments per GAMP 5. Each risk has owner, severity / occurrence / detectability scores, current controls, residual risk, mitigation actions, and review cadence.

Risk drives behaviour. Sampling plans are scaled to material risk class. Change controls inherit a default risk assessment template by change type. Validation depth (URS → IQ/OQ/PQ effort) scales to GAMP category. Audit frequency for a supplier scales to that supplier's risk profile and historical performance. When residual risk crosses a threshold, V5 raises a CAPA automatically.

  • FMEA, HACCP, PHA, GAMP risk assessments — one repository
  • Risk scores drive sampling, validation depth, audit frequency
  • Auto-CAPA when residual risk crosses configured threshold
  • Periodic re-assessment scheduling per risk type
Regulatory anchors
  • ICH Q9 (R1)Quality Risk Management
  • ISO 14971Risk management — medical devices (cross-referenced)
  • GAMP 5 Appendix M3Risk-based approach to validation
20

Stability programme management

Stability protocols, pull schedules, sample inventory and trended results — managed natively, regulator-ready.

V5 hosts the stability programme per product / strength / pack / climate zone. Protocols are versioned: ICH Q1A long-term, intermediate, accelerated, in-use, stress, photostability. The pull schedule is generated automatically and surfaces in the QC kiosk on its due date; samples carry the originating batch context so any trended drift can be traced to its source.

Results land in the same trend engine as in-process QC — Arrhenius and shelf-life projection models flag any test approaching spec before it crosses. Out-of-trend (OOT) triggers an investigation; out-of-spec (OOS) triggers a market-impact assessment, a stability commitment review and, if warranted, a controlled recall workflow.

  • Protocol library: long-term, intermediate, accelerated, in-use, stress, photostability
  • Auto-generated pull schedule per condition × time point
  • Trend engine: Arrhenius / shelf-life projection with OOT alerts
  • OOS triggers market-impact assessment + recall workflow if warranted
Regulatory anchors
  • ICH Q1A (R2)Stability testing of new drug substances and products
  • 21 CFR 211.166Stability testing programme
  • EU GMP Ch. 6 §6.32Ongoing stability programme
21

Environmental monitoring (EM) & utilities

Viable, non-viable, temperature, humidity, differential pressure, water and gases — all streamed to the same ledger as production.

V5 ingests EM data from particle counters, viable air / surface plates, RODAC sampling, glove-print monitoring, and continuous instruments (T, RH, ΔP, dew point, TOC for purified / WFI water, microbial / endotoxin trends). Sampling plans are gridded to the clean-room map and scheduled per area grade (ISO 5/A, ISO 7/B, ISO 8/C, etc.).

Alert and action limits are codified per location; excursions auto-route to QA, link to the batches in production at the time, and gate release if the impact assessment is open. Annex 1 (2022) contamination control strategy (CCS) is supported as a living document — each control referenced back to the data feed and the SOP that owns it.

  • Live ingestion: particle, viable, ΔP, T/RH, water (PW / WFI), gases
  • Grade-aware sampling plan gridded to the clean-room map
  • Alert / action limit excursions tied to in-flight batches automatically
  • Annex 1 Contamination Control Strategy as a living document
Regulatory anchors
  • EU GMP Annex 1 (2022)Manufacture of sterile medicinal products
  • USP <1116>Microbiological control & monitoring of aseptic processing
  • ISO 14644-1/-2Cleanroom classification & monitoring
22

Cleaning validation & changeover control

Product-to-product and campaign-to-campaign changeovers run on a verified protocol — never on memory.

V5 manages the cleaning matrix: every product pair × shared equipment train, with the carry-over limit calculated from PDE / HBEL (ICH Q3D and EMA guideline), the worst-case soil, the validated cleaning SOP, swab and rinse sample plans, and the analytical method. Changeover at the kiosk follows the protocol step by step; results return from the lab and a clean-status flag flips on the equipment train.

Released equipment carries a 'clean window' — if the next run isn't kicked off inside it, V5 forces a re-clean or a hold-time validation reference. Periodic re-validation is calendar-driven and re-triggered automatically when a new product enters the train or a cleaning SOP is revised.

  • Product-pair cleaning matrix with PDE / HBEL-based carry-over limits
  • Kiosk-led changeover protocol with swab / rinse sample capture
  • Clean-window expiry with auto-hold for over-due re-clean
  • Auto re-validation trigger on new product or SOP revision
Regulatory anchors
  • EU GMP Annex 15Qualification and validation — cleaning validation
  • EMA/CHMP/CVMP/SWP/169430/2012Setting health-based exposure limits (PDE / HBEL)
  • ICH Q3D (R2)Elemental impurities
23

Equipment lifecycle, calibration & preventive maintenance

Every asset on the floor has a digital twin record — qualification, calibration, PM, breakdowns, parts and disposition.

V5 holds the asset register: equipment ID, location, manufacturer, model, qualification status (DQ / IQ / OQ / PQ with linked validation packs), calibration plan, PM plan, change history, criticality classification. Calibration certificates are stored with as-found / as-left values; any out-of-tolerance triggers a back-look assessment against batches the instrument touched since the last successful calibration.

PM is scheduled by runtime hours, calendar, or condition (vibration, particle count). Open work orders for an instrument prevent its scheduling on a production routing. Spare-parts inventory is linked; minimum stocks per critical asset trigger a purchase requisition before a breakdown. Decommissioning is a controlled workflow with data-archive and verification.

  • DQ / IQ / OQ / PQ pack per asset, linked to qualification status
  • Calibration with as-found / as-left and automatic back-look on OOT
  • PM scheduled by runtime / calendar / condition
  • Spare-parts inventory with min-stock auto-PR
  • Controlled decommissioning with data-archive verification
Regulatory anchors
  • 21 CFR 211.63Equipment design, size & location
  • 21 CFR 211.68Automatic, mechanical & electronic equipment
  • EU GMP Annex 15Qualification and validation lifecycle
24

Complaints, returns & pharmacovigilance intake

Market signal lands in one queue — triaged, investigated, linked to batch evidence, and (for safety signals) escalated to PV.

V5 ingests complaints from the customer portal, sales / CSM channels, and a generic API for external case-management or call-centre systems. Each case opens with reporter, product, lot / serial (look-up enforced), category (quality / labelling / packaging / suspected adverse event), severity and reportability assessment. The case auto-links to the BMR for the implicated batch and to any other open complaints on the same lot.

Investigations route to QA with a structured root-cause workflow (5-Why, fishbone, Ishikawa templates). Returns are reconciled against the original shipment, with disposition (re-stock / re-work / destroy) recorded against the same ledger. Suspected adverse events feed a pharmacovigilance intake module — case narrative, MedDRA coding, expedited reporting decision (CIOMS / E2B), and audit trail of every regulator transmission.

  • Multi-channel intake: portal, CSM, API into one queue
  • Lot / serial look-up enforced — no orphan complaints
  • Auto-link to BMR + other open cases on the same lot
  • Structured RCA templates (5-Why, fishbone, Ishikawa)
  • PV intake module with MedDRA coding + E2B export
Regulatory anchors
  • 21 CFR 211.198Complaint files (US)
  • EU GMP Ch. 8Complaints, quality defects & product recalls
  • ICH E2D / E2BPharmacovigilance — post-approval safety data management
Part VIII

Compliance, experience & onboarding

Part 11 evidence, customer surface, onboarding, full regulatory matrix.

25

Data integrity & 21 CFR Part 11 evidence map

ALCOA+ in nine letters; in V5, in every record. Here's where the evidence lives.

Attributable — every action is bound to an identity-verified user account. Legible — every record renders in human-readable form on demand, with the original raw value retained. Contemporaneous — actions write at the moment they happen, not at end-of-shift. Original — raw instrument readings are captured and retained; transformations are versioned. Accurate — tolerances, calculations, and validation rules are codified, not described.

Plus: Complete (no fragmenting across spreadsheets), Consistent (one ledger), Enduring (immutable audit trail, time-stamped), Available (queryable for the full retention period). GAMP 5 CSA is the validation posture — risk-based testing focused on patient impact, with documented evidence the system does what the URS says.

  • Identity-verified e-signatures (username + password + second factor where required)
  • Tamper-evident audit trail — append-only, time-stamped
  • Raw instrument data retained alongside transformed values
  • Validation pack: URS → FS → DS → IQ → OQ → PQ → traceability matrix
Regulatory anchors
  • 21 CFR Part 11Electronic records & signatures (US)
  • EU GMP Annex 11Computerised systems (EU)
  • GAMP 5 / CSARisk-based validation approach
  • MHRA Data IntegrityMHRA & FDA Data Integrity guidance
26

What the customer sees — portals, reports, audits

The customer-facing surface is small on purpose: a few portals, a few reports, instant evidence on demand.

Supplier portal for COAs, audits, change notifications, and document acknowledgements. Customer portal for CoAs, shipment pedigree, complaint submission, and document subscriptions. QA dashboard for KPIs (RFT, OOS rate, deviation cycle time, CAPA closure rate, audit-finding age). Investigator-mode for FDA / EMA / MHRA / local inspectors — read-only, scoped to the inspection window, with one-click evidence export.

Reports are generated from the live ledger, not built from an export. When a regulator asks 'show me batch X', the answer is a URL, not a PDF emailed at 11pm.

  • Supplier portal — COA upload, audit ack, change notification
  • Customer portal — CoA + pedigree + complaint submission
  • Investigator-mode for read-only scoped inspections
  • Live reports — no export-and-format step
Regulatory anchors
  • ICH Q10 §3Management responsibilities — transparency & oversight
27

Onboarding & support model

Onboarding in days, not months. A CSM owns your readiness for the first 90 days.

Onboarding follows a fixed playbook: site discovery → import of supplier master / material master / MMR library → role mapping → kiosk hardware list → validation pack tailored to your products → operator training → go-live walk-through. Most sites are running first batches on V5 inside three weeks; full PQS migration completes inside a quarter.

Support is tiered: a 24/7 incident channel for floor-stopping issues, a CSM for adoption and change control, a regulatory advisor for inspection prep, and a quarterly platform review to surface emerging risks and KPI drift.

  • Fixed onboarding playbook — predictable cost and timeline
  • 24/7 incident channel for floor-stopping issues
  • Dedicated CSM for the first 90 days, ongoing for paid tiers
  • Quarterly platform review with regulatory advisor
28

Appendix A — Regulatory cross-reference matrix

Where every clause lands in the V5 product surface. Short version below; the full matrix is on the relevant guides.

This is the abbreviated mapping. Each link below opens the full readiness guide for that regulation.

RegulationScopeTouchpointsGuide
21 CFR 211 (cGMP, finished pharma)Production, records, release, distributionAllRead →
21 CFR Part 11Electronic records & signatures06, 08, 12, 15Read →
ICH Q7 (API GMP)Active pharmaceutical ingredients GMP03–10Read →
ICH Q9 (Quality Risk Management)Risk-based decisions09, 10, 14Read →
ICH Q10 (PQS)Pharmaceutical Quality System14, 17Read →
EU GMP Annex 11Computerised systems (EU)06, 08, 12, 15Read →
EU GMP Annex 1Sterile manufacturing08, 09, 14Read →
EU GDPGood Distribution Practice05, 13Read →
EU FMDFalsified Medicines Directive — serialisation11, 13Read →
DSCSADrug Supply Chain Security Act (US)11, 13Read →
GAMP 5 / CSARisk-based validation15Read →

See the playbook running on your floor.

Free trial, no credit card, onboard in days, not months.